Institute of Physiology, Univ. of Regensburg, Universitätsstr. 31, 93040 Regensburg, Germany.
Am J Physiol Renal Physiol. 2012 May 15;302(10):F1313-24. doi: 10.1152/ajprenal.00620.2011. Epub 2012 Feb 22.
Arap1 is a protein that interacts with angiotensin II type 1 (AT(1)) receptors and facilitates increased AT(1) receptor surface expression in vitro. In the present study, we assessed the tissue localization and regulation of Arap1 in vivo. Arap1 was found in various mouse organs, with the highest expression in the heart, kidney, aorta, and adrenal gland. Renal Arap1 protein was restricted to the vasculature and to glomerular mesangial cells and was absent from tubular epithelia. A similar localization was found in human kidneys. To test the hypothesis that angiotensin II may control renal Arap1 expression, mice were subjected to various conditions to alter the activity of the renin-angiotensin system. A high-salt diet (4% NaCl, 7 days) upregulated Arap1 expression in mice by 47% compared with controls (0.6% NaCl, P = 0.03). Renal artery stenosis (7 days) or water restriction (48 h) suppressed Arap1 levels compared with controls (-64 and -62% in the clipped and contralateral kidney, respectively; and -50% after water restriction, P < 0.01). Angiotensin II infusion (2 μg·kg(-1)·min(-1), 7 days) reduced Arap1 mRNA levels compared with vehicle by 29% (P < 0.01), whereas AT(1) antagonism (losartan, 30 mg·kg(-1)·day(-1), 7 days) enhanced Arap1 mRNA expression by 52% (P < 0.01); changes in mRNA were paralleled by Arap1 protein abundance. Experiments with hydralazine and epithelial nitric oxide synthase-/- mice further suggested that Arap1 expression changed in parallel with angiotensin II, rather than with blood pressure per se. Similar to in vivo, Arap1 mRNA and protein were suppressed by angiotensin II in a time- and dose-dependent manner in cultured mesangial cells. In summary, Arap1 is highly expressed in the renal vasculature, and its expression is suppressed by angiotensin II. Thus Arap1 may serve as a local modulator of vascular AT(1) receptor function in vivo.
Arap1 是一种与血管紧张素 II 型 1(AT(1))受体相互作用的蛋白,可促进体外 AT(1)受体表面表达增加。在本研究中,我们评估了 Arap1 在体内的组织定位和调节。Arap1 存在于各种小鼠器官中,在心脏、肾脏、主动脉和肾上腺中表达最高。肾脏 Arap1 蛋白仅限于血管和肾小球系膜细胞,而不存在于肾小管上皮细胞中。在人类肾脏中也发现了类似的定位。为了测试血管紧张素 II 可能控制肾脏 Arap1 表达的假设,我们让小鼠处于各种改变肾素-血管紧张素系统活性的条件下。与对照组(0.6%NaCl,P=0.03)相比,高盐饮食(4%NaCl,7 天)使小鼠的 Arap1 表达增加了 47%。肾动脉狭窄(7 天)或限水(48 小时)使 Arap1 水平与对照组相比分别降低了 64%和 62%(夹闭侧和对侧肾脏),限水后降低了 50%(P<0.01)。血管紧张素 II 输注(2μg·kg(-1)·min(-1),7 天)使 Arap1 mRNA 水平与载体相比降低了 29%(P<0.01),而 AT(1)拮抗(氯沙坦,30mg·kg(-1)·天(-1),7 天)使 Arap1 mRNA 表达增加了 52%(P<0.01);mRNA 的变化与 Arap1 蛋白丰度平行。用肼屈嗪和上皮型一氧化氮合酶-/-小鼠进行的实验进一步表明,Arap1 的表达与血管紧张素 II 平行变化,而不是与血压本身平行变化。与体内相似,血管紧张素 II 以时间和剂量依赖的方式在培养的系膜细胞中抑制 Arap1 mRNA 和蛋白的表达。总之,Arap1 在肾脏血管中高度表达,其表达受血管紧张素 II 抑制。因此,Arap1 可能作为体内血管 AT(1)受体功能的局部调节剂。